SCHEMBL31428668

SCHEMBL31428668

CC(=O)N1C(=Cc2ccc(OCC(N)=O)c(F)c2)C(=O)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.53
▸ MAPT P10636 2/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ CES1 P23141 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ KCNN4 O15554 1/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ AKR1B1 P15121 2/20 0.36
▸ ADRB2 P07550 1/20 0.36
▸ SNCA P37840 1/20 0.36
▸ PTPN2 P17706 1/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ ACP1 P24666 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30163485 0.89 MAPT (0.53) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31428526 0.89 ALDH1A1 (0.53) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31428729 0.88 ALDH1A1 (0.54) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31428779 0.87 ALDH1A1 (0.50) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31428705 0.84 ALDH1A1 (0.61) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31429004 0.84 MAPT (0.53) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31428724 0.84 FKBP1A (0.53) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31428577 0.82 ALDH1A1 (0.50) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL30163547 0.80 ALDH1A1 (0.53) ALDH1A1MAPTMAPK1HTTSMN1; SMN2
SCHEMBL31428956 0.79 KMT2A (0.52) ALDH1A1MAPTSMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS ALDH1A1 2352/4885MAPT 4513/4885MAPK1 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback